Endothelial-to-mesenchymal transition induced by Wnt 3a in keloid pathogenesis

Wound Repair and Regeneration

Volumn 23, Issue 3, 2015, Pages 435-442

  Lee, Won Jai ^a   Park, Ji Hun ^a   Shin, Jung U ^a   Noh, Hyun ^a   Lew, Dae Hyun ^a   Yang, Woo Ick ^a   Yun, Chae Ok ^b   Lee, Kwang Hoon ^a   Lee, Ju Hee ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Hanyang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; VASCULAR ENDOTHELIAL CADHERIN; VIMENTIN; WNT3A PROTEIN; VASCULOTROPIN A;

ADOLESCENT; ADULT; ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DERMAL MICROVASCULAR ENDOTHELIAL CELL; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; KELOID; MALE; MIDDLE AGED; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIUM; YOUNG ADULT; AGED; CELL CULTURE; CELL PROLIFERATION; CYTOLOGY; DOWN REGULATION; DRUG EFFECTS; ENDOTHELIUM CELL; EPITHELIUM CELL; FIBROBLAST; HYPERTROPHIC SCAR; METABOLISM; PATHOLOGY; WNT SIGNALING PATHWAY; WOUND HEALING;

ADOLESCENT; ADULT; AGED; CELL PROLIFERATION; CELLS, CULTURED; CICATRIX, HYPERTROPHIC; DOWN-REGULATION; ENDOTHELIAL CELLS; EPITHELIAL CELLS; FEMALE; FIBROBLASTS; HUMANS; IMMUNOHISTOCHEMISTRY; KELOID; MALE; MIDDLE AGED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WNT SIGNALING PATHWAY; WNT3A PROTEIN; WOUND HEALING;

EID: 84938062510     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/wrr.12300     Document Type: Article

References (40)

1. Burd A, Huang L,. Hypertrophic response and keloid diathesis: two very different forms of scar. Plast Reconstr Surg 2005; 116: 150-7e.
2. Tuan TL, Nichter LS,. The molecular basis of keloid and hypertrophic scar formation. Mol Med Today 1998; 4: 19-24.
3. Niessen FB, Spauwen PH, Schalkwijk J, Kon M,. On the nature of hypertrophic scars and keloids: a review. Plast Reconstr Surg 1999; 104: 1435-58.
4. Luo S, Benathan M, Raffoul W, Panizzon RG, Egloff DV,. Abnormal balance between proliferation and apoptotic cell death in fibroblasts derived from keloid lesions. Plast Reconstr Surg 2001; 107: 87-96.
5. Tredget EE, Shankowsky HA, Pannu R, Nedelec B, Iwashina T, Ghahary A, et al., Transforming growth factor-beta in thermally injured patients with hypertrophic scars: effects of interferon alpha-2b. Plast Reconstr Surg 1998; 102: 1317-28; discussion 29.
6. Kikuchi K, Kadono T, Takehara K,. Effects of various growth factors and histamine on cultured keloid fibroblasts. Dermatology 1995; 190: 4-8.
7. Kis K, Liu X, Hagood JS,. Myofibroblast differentiation and survival in fibrotic disease. Expert Rev Mol Med 2011; 13: e27.
8. Gabbiani G,. The myofibroblast in wound healing and fibrocontractive diseases. J Pathol 2003; 200: 500-3.
9. Hinz B,. Formation and function of the myofibroblast during tissue repair. J Invest Dermatol 2007; 127: 526-37.
10. Yan C, Grimm WA, Garner WL, Qin L, Travis T, Tan N, Han YP,. Epithelial to mesenchymal transition in human skin wound healing is induced by tumor necrosis factor-alpha through bone morphogenic protein-2. Am J Pathol 2010; 176: 2247-58.
11. Xu J, Lamouille S, Derynck R,. TGF-beta-induced epithelial to mesenchymal transition. Cell Res 2009; 19: 156-72.
12. Nakamura M, Tokura Y,. Epithelial-mesenchymal transition in the skin. J Dermatol Sci 2011; 61: 7-13.
13. Yoshimatsu Y, Watabe T,. Roles of TGF-beta signals in endothelial-mesenchymal transition during cardiac fibrosis. Int J Inflam 2011; 2011: 724080.
14. van Meeteren LA, ten Dijke P,. Regulation of endothelial cell plasticity by TGF-beta. Cell Tissue Res 2012; 347: 177-86.
15. Schrimpf C, Duffield JS,. Mechanisms of fibrosis: the role of the pericyte. Curr Opin Nephrol Hypertens 2011; 20: 297-305.
16. Grieb G, Steffens G, Pallua N, Bernhagen J, Bucala R,. Circulating fibrocytes-biology and mechanisms in wound healing and scar formation. Int Rev Cell Mol Biol 2011; 291: 1-19.
17. Kisanuki YY, Hammer RE, Miyazaki J, Williams SC, Richardson JA, Yanagisawa M,. Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. Dev Biol 2001; 230: 230-42.
18. DeRuiter MC, Poelmann RE, VanMunsteren JC, Mironov V, Markwald RR, Gittenberger-de Groot AC,. Embryonic endothelial cells transdifferentiate into mesenchymal cells expressing smooth muscle actins in vivo and in vitro. Circ Res 1997; 80: 444-51.
19. Piera-Velazquez S, Jimenez SA,. Molecular mechanisms of endothelial to mesenchymal cell transition (EndoMT) in experimentally induced fibrotic diseases. Fibrogenesis Tissue Repair 2012; 5 Suppl 1: S7.
20. Li J, Bertram JF,. Review: endothelial-myofibroblast transition, a new player in diabetic renal fibrosis. Nephrology (Carlton) 2010; 15: 507-12.
21. Gitler AD, Lu MM, Jiang YQ, Epstein JA, Gruber PJ,. Molecular markers of cardiac endocardial cushion development. Dev Dyn 2003; 228: 643-50.
22. Arciniegas E, Frid MG, Douglas IS, Stenmark KR,. Perspectives on endothelial-to-mesenchymal transition: potential contribution to vascular remodeling in chronic pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2007; 293: L1-8.
23. Piera-Velazquez S, Li Z, Jimenez SA,. Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders. Am J Pathol 2011; 179: 1074-80.
24. Kitao A, Sato Y, Sawada-Kitamura S, Harada K, Sasaki M, Morikawa H, et al., Endothelial to mesenchymal transition via transforming growth factor-beta1/Smad activation is associated with portal venous stenosis in idiopathic portal hypertension. Am J Pathol 2009; 175: 616-26.
25. Xi-Qiao W, Ying-Kai L, Chun Q, Shu-Liang L,. Hyperactivity of fibroblasts and functional regression of endothelial cells contribute to microvessel occlusion in hypertrophic scarring. Microvasc Res 2009; 77: 204-11.
26. Karasek MA,. Does transformation of microvascular endothelial cells into myofibroblasts play a key role in the etiology and pathology of fibrotic disease? Med Hypotheses 2007; 68: 650-5.
27. Chaudhuri V, Zhou L, Karasek M,. Inflammatory cytokines induce the transformation of human dermal microvascular endothelial cells into myofibroblasts: a potential role in skin fibrogenesis. J Cutan Pathol 2007; 34: 146-53.
28. Akhmetshina A, Palumbo K, Dees C, Bergmann C, Venalis P, Zerr P, et al., Activation of canonical Wnt signalling is required for TGF-beta-mediated fibrosis. Nat Commun 2012; 3: 735.
29. Labus MB, Stirk CM, Thompson WD, Melvin WT,. Expression of Wnt genes in early wound healing. Wound Repair Regen 1998; 6: 58-64.
30. Lam AP, Gottardi CJ,. beta-catenin signaling: a novel mediator of fibrosis and potential therapeutic target. Curr Opin Rheumatol 2011; 23: 562-7.
31. Colwell AS, Krummel TM, Longaker MT, Lorenz HP,. Wnt-4 expression is increased in fibroblasts after TGF-beta1 stimulation and during fetal and postnatal wound repair. Plast Reconstr Surg 2006; 117: 2297-301.
32. He W, Dai C, Li Y, Zeng G, Monga SP, Liu Y,. Wnt/beta-catenin signaling promotes renal interstitial fibrosis. J Am Soc Nephrol 2009; 20: 765-76.
33. Konigshoff M, Balsara N, Pfaff EM, Kramer M, Chrobak I, Seeger W, et al., Functional Wnt signaling is increased in idiopathic pulmonary fibrosis. PLoS One 2008; 3: e2142.
34. Igota S, Tosa M, Murakami M, Egawa S, Shimizu H, Hyakusoku H, et al., Identification and characterization of Wnt signaling pathway in keloid pathogenesis. Int J Med Sci 2013; 10: 344-54.
35. Sato M,. Upregulation of the Wnt/beta-catenin pathway induced by transforming growth factor-beta in hypertrophic scars and keloids. Acta Derm Venereol 2006; 86: 300-7.
36. Chua AW, Gan SU, Ting Y, Fu Z, Lim CK, Song C, et al., Keloid fibroblasts are more sensitive to Wnt3a treatment in terms of elevated cellular growth and fibronectin expression. J Dermatol Sci 2011; 64: 199-209.
37. Zeisberg EM, Potenta SE, Sugimoto H, Zeisberg M, Kalluri R,. Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J Am Soc Nephrol 2008; 19: 2282-7.
38. Whiteman EL, Liu CJ, Fearon ER, Margolis B,. The transcription factor snail represses Crumbs3 expression and disrupts apico-basal polarity complexes. Oncogene 2008; 27: 3875-9.
39. Turley EA, Veiseh M, Radisky DC, Bissell MJ,. Mechanisms of disease: epithelial-mesenchymal transition-does cellular plasticity fuel neoplastic progression? Nat Clin Pract Oncol 2008; 5: 280-90.
40. Janda E, Lehmann K, Killisch I, Jechlinger M, Herzig M, Downward J, et al., Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways. J Cell Biol 2002; 156: 299-313.